Heart failure drug trial pulled before it even started
Disease control
Terminated
This study was designed to test a drug called CDR132L in about 130 people with a type of heart failure where the heart pumps normally but is stiff. The goal was to see if the drug could reverse harmful changes in the heart muscle. However, the trial was withdrawn before any parti…
Phase: PHASE2 • Sponsor: Cardior Pharmaceuticals GmbH • Aim: Disease control
Last updated May 17, 2026 12:53 UTC